FinTrust Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.45M | Sell |
12,393
-37
| -0.3% | -$7.31K | 0.41% | 49 |
|
|
2024
Q2 | $2.13M | Buy |
12,430
+666
| +6% | +$114K | 0.39% | 51 |
|
|
2024
Q1 | $2.14M | Buy |
11,764
+225
| +2% | +$41K | 0.41% | 49 |
|
|
2023
Q4 | $1.79M | Sell |
11,539
-177
| -2% | -$27.4K | 0.36% | 57 |
|
|
2023
Q3 | $1.75M | Buy |
11,716
+958
| +9% | +$143K | 0.39% | 53 |
|
|
2023
Q2 | $1.74M | Hold |
10,758
| – | – | 0.42% | 58 |
|
|
2023
Q1 | $1.74M | Hold |
10,758
| – | – | 0.42% | 59 |
|
|
2022
Q4 | $1.74M | Sell |
10,758
-223
| -2% | -$36K | 0.42% | 60 |
|
|
2022
Q3 | $1.59M | Buy |
10,981
+656
| +6% | +$94.9K | 0.41% | 59 |
|
|
2022
Q2 | $1.53M | Buy |
10,325
+485
| +5% | +$72K | 0.38% | 63 |
|
|
2022
Q1 | $1.6M | Buy |
9,840
+1,681
| +21% | +$272K | 0.37% | 65 |
|
|
2021
Q4 | $1.11M | Buy |
8,159
+4,041
| +98% | +$547K | 0.26% | 80 |
|
|
2021
Q3 | $444K | Buy |
4,118
+35
| +0.9% | +$3.77K | 0.12% | 155 |
|
|
2021
Q2 | $460K | Buy |
4,083
+104
| +3% | +$11.7K | 0.12% | 150 |
|
|
2021
Q1 | $431K | Sell |
3,979
-8
| -0.2% | -$867 | 0.12% | 149 |
|
|
2020
Q4 | $427K | Sell |
3,987
-753
| -16% | -$80.6K | 0.14% | 136 |
|
|
2020
Q3 | $415 | Sell |
4,740
-1,325
| -22% | -$116 | 0.08% | 135 |
|
|
2020
Q2 | $595K | Sell |
6,065
-817
| -12% | -$80.2K | 0.24% | 86 |
|
|
2020
Q1 | $524K | Sell |
6,882
-1,264
| -16% | -$96.2K | 0.25% | 85 |
|
|
2019
Q4 | $721K | Sell |
8,146
-175
| -2% | -$15.5K | 0.29% | 72 |
|
|
2019
Q3 | $630K | Sell |
8,321
-1,312
| -14% | -$99.3K | 0.22% | 82 |
|
|
2019
Q2 | $701K | Sell |
9,633
-41
| -0.4% | -$2.98K | 0.28% | 71 |
|
|
2019
Q1 | $779K | Buy |
9,674
+366
| +4% | +$29.5K | 0.33% | 57 |
|
|
2018
Q4 | $858K | Buy |
+9,308
| New | +$858K | 0.42% | 49 |
|